Changes in the sterol composition of the plasma membrane affect membrane potential, salt tolerance and the activity of multidrug resistance pumps in Saccharomyces cerevisiae

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Kodedová, Marie ^a   Sychrová, Hana ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; PDR5 PROTEIN; SNQ2P PROTEIN; STEROL; UNCLASSIFIED DRUG; ABC TRANSPORTER; ANTIFUNGAL AGENT; DELTA 24-STEROL METHYLTRANSFERASE; ERGOSTEROL; FLUCONAZOLE; METHYLTRANSFERASE; PDR5 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN; SNQ2 PROTEIN, S CEREVISIAE;

ANTIFUNGAL RESISTANCE; ARTICLE; CELL MEMBRANE; CHEMICAL COMPOSITION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ERG2 GENE; ERG3 GENE; ERG4 GENE; ERG5 GENE; ERG6 GENE; GENE; GENE DELETION; HYPEROSMOTIC STRESS; HYPERPOLARIZATION; MEMBRANE POTENTIAL; MULTIDRUG RESISTANCE; MUTANT; NONHUMAN; PHENOTYPE; SACCHAROMYCES CEREVISIAE; SALT STRESS; SALT TOLERANCE; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; MUTATION; PH; PHYSIOLOGY;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOSYNTHETIC PATHWAYS; CELL MEMBRANE; DRUG RESISTANCE, MULTIPLE, FUNGAL; ERGOSTEROL; FLUCONAZOLE; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; METHYLTRANSFERASES; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; MUTATION; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SALT-TOLERANCE;

EID: 84947969194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139306     Document Type: Article

References (56)

1. Dupont S, Lemetais G, Ferreira T, Cayot P, Gervais P, Beney L. Ergosterol biosynthesis: a fungal pathway for life on land? Evolution. 2012; 66: 2961-2968.
2. Caspeta L, Chen Y, Ghiaci P, Feizi A, Buskov S, Hallström BM, et al. Altered sterol composition renders yeast thermotolerant. Science. 2014; 346: 75-78.
3. Guan XL, Souza CM, Pichler H, Dewhurst G, Schaad O, Kajiwara K, et al. Functional interactions between sphingolipids and sterols in biological membranes regulating cell physiology. Mol Biol Cell. 2009; 20: 2083-2095.
4. Spanova M, Zweytick D, Lohner K, Klug L, Leitner E, Hermetter A. Influence of squalene on lipid particle/droplet and membrane organization in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta. 2012; 1821: 647-653.
5. Aguilar PS, Heiman MG, Walther TC, Engel A, Schwudke D, Gushwa N, et al. Structure of sterol aliphatic chains affects yeast cell shape and cell fusion during mating. PNAS. 2010; 107: 4170-4175.
6. Heese-Peck A, Pichler H, Zanolari B, Watanabe R, Daum G, Riezman H. Multiple functions of sterols in yeast endocytosis. Mol Biol Cell. 2002; 13: 2664-2680.
7. Jacquier N, Schneiter R. Mechanisms of sterol uptake and transport in yeast. J Steroid Biochem Mol Biol. 2012; 129: 70-78.
8. Tiedje C, Holland DG, Just U, Höfken T. Proteins involved in sterol synthesis interact with Ste20 and regulate cell polarity. J Cell Sci. 2007; 120: 3613-3624.
9. Klug L, Daum G. Yeast lipid metabolism at a glance. FEMS Yeast Res. 2014; 14: 369-388.
10. Parks LW, Casey WM. Physiological implications of sterol biosynthesis in yeast. Annu Rev Microbiol. 1995; 49: 95-116.
11. Weete JD, Abril M, Blackwell M. Phylogenetic distribution of fungal sterols. PLoS ONE. 2010; 5: e10899.
12. Bard M, Sturm AM, Pierson CA, Brown S, Rogers KM, Nabinger S, et al. Sterol uptake in Candida glabrata: Rescue of sterol auxotrophic strains. Diagn Microbiol Infect Dis. 2005; 52: 285-293.
13. Hazen KC, Stei J, Darracott C, Breathnach A, May J, Howell SA. Isolation of cholesterol-dependent Candida glabrata from clinical specimens. Diagn Microbiol Infect Dis. 2005; 52: 35-37.
14. Xiong Q, Hassan SA, Wilson WK, Han XY, May GS, Tarrand JJ, et al. Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2005; 49: 518-524.
15. Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993; 326:285-8.
16. Daum G, Lees ND, Bard M, Dickson R. Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae. Yeast. 1998; 14: 1471-1510.
17. Lees ND, Skaggs B, Kirsch DR, Bard M. Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae - A review. Lipids. 1995; 30: 221-226.
18. Malínský J, Opekarová M, Tanner W. The lateral compartmentation of the yeast plasma membrane. Yeast. 2010; 27: 473-478.
19. Merzendorfer H, Heinisch JJ. Microcompartments within the yeast plasma membrane. Biol Chem. 2013; 394: 189-202.
20. Mollinedo F. Lipid raft involvement in yeast cell growth and death. Front Oncol. 2012; 2: 140.
21. Spira F, Mueller NS, Beck G, von Olshausen P, Beig J, Wedlich-Söldner R. Patchwork organization of the yeast plasma membrane into numerous coexisting domains. Nat Cell Biol. 2012; 14: 640-648.
22. Marty A, Finkelstein A. Pores formed in lipid bilayer membranes by nystatin. J Gen Physiol. 1975; 65: 515-526.
23. Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev. 1988; 1: 187-217.
24. Shalini K, Kumar N, Drabu S, Sharma PK. Advances in synthetic approach to and antifungal activity of triazoles. Beilstein J Org Chem. 2011; 7: 668-677.
25. Marešová L, Hošková B, Urbánková E, Chaloupka R, Sychrová H. New applications of pHluorin-measuring intracellular pH of prototrophic yeasts and determining changes in the buffering capacity of strains with affected potassium homeostasis. Yeast. 2010; 27: 317-325.
26. Miesenböck G, De Angelis DA, Rothman JE. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature. 1998; 394: 192-195.
27. Güldener U, Heck S, Fielder T, Beinhauer J, Hegemann JH. A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res. 1996; 24: 2519-2524.
28. Hill JE, Myers AM, Koerner TJ, Tzagoloff A. Yeast/E. coli shuttle vectors with multiple unique restriction sites. Yeast. 1986; 2: 163-167.
29. Myers AM, Tzagoloff A, Kinney DM, Lusty CJ. Yeast shuttle and integrative vectors with multiple cloning sites suitable for construction of lacZ fusions. Gene. 1986; 45: 299-310.
30. Kinclová O, Ramos J, Potier S, Sychrová H. Functional study of the Saccharomyces cerevisiae Nha1p C-terminus. Mol Microbiol. 2001; 40: 656-668.
31. Hendrych T, Kodedová M, Sigler K, Gásková D. Characterization of the kinetics and mechanisms of inhibition of drugs interacting with the S. cerevisiae multidrug resistance pumps Pdr5p and Snq2p. Biochim Biophys Acta. 2009; 1788: 717-723.
32. 3(3) fluorescence. Folia Microbiol. 1997; 42: 221-224.
33. 3(3) assay in Saccharomyces cerevisiae. Yeast. 1998; 14:1189-1197.
34. Orij R, Postmus J, Ter Beek A, Brul S, Smits GJ. In vivo measurement of cytosolic and mitochondrial pH using a pH-sensitive GFP derivative in Saccharomyces cerevisiae reveals a relation between intracellular pH and growth. Microbiology. 2009; 155: 268-278.
35. Heřman P, Večeř J, Opekarová M, Veselá P, Jancíková I, Zahumenský J, et al. Depolarization affects the lateral microdomain structure of yeast plasma membrane. FEBS Journal. 2015; 282: 419-434.
36. Herrera R, Álvarez MC, Gelis S, Kodedová M, Sychrová H, Kschischo M, et al. Role of Saccharomyces cerevisiae Trk1 in stabilization of intracellular potassium content upon changes in external potassium levels. Biochim Biophys Acta. 2014; 1838:127-133.
37. Čadek R, Chládková K, Sigler K, Gásková D. Impact of the growth phase on the activity of multidrug resistance pumps and membrane potential of S. cerevisiae: effect of pump overproduction and carbon source. Biochim Biophys Acta. 2004; 1665:111-117.
38. Ren B, Dai HQ, Pei G, Tong YJ, Zhuo Y, Yang N, et al. ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility. Appl Microbiol Biotechnol. 2014; 98: 2609-2616.
39. Ariño J, Ramos J, Sychrová H. Alkali metal cation transport and homeostasis in yeasts. Microbiol Mol Biol Rev. 2010; 74: 95-120.
40. Welihinda AA, Beavis AD, Trumbly RJ. Mutations in LIS1 (ERG6) gene confer increased sodium and lithium uptake in Saccharomyces cerevisiae. Biochim Biophys Acta. 1994; 1193:107-117.
41. Barreto L, Canadell D, Petrezsélyová S, Navarrete C, Marešová L, Peréz-Valle J, et al. Agenomewide screen for tolerance to cationic drugs reveals genes important for potassium homeostasis in Saccharomyces cerevisiae. Eukaryot Cell. 2011; 10:1241-1250.
42. Szopinska A, Degand H, Hochstenbach J-F, Nader J, Morsomme P. Rapid response of the yeast plasma membrane proteome to salt stress. Mol Cell Proteomics. 2011; 10: M111.009589.
43. Käufer NF, Fried HM, Schwindinger WF, Jasin M, Warner JR. Cycloheximide resistance in yeast: the gene and its protein. Nucleic Acids Res. 1983; 11: 3123-3135.
44. Kodedová M, Sigler K, Lemire BD, Gásková D. Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. BioTechniques. 2011; 50: 58-63.
45. Anderson JB, Sirjusingh C, Parsons AB, Boone C, Wickens C, Cowen LE, et al. Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics. 2003; 163:1287-1298.
46. Kralli A, Yamamoto KR. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J BiolChem. 1996; 271:17152-17156.
47. Decottignies A, Lambert L, Catty P, Degand H, Epping EA, Moye-Rowley WS, et al. Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J Biol Chem. 1995; 270:18150-18157.
48. Emter R, Heese-Peck A, Kralli A. ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms. FEBS Letters. 2002; 521: 57-61.
49. Kaur R, Bachhawat AK. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. Microbiology. 1999; 145: 809-818.
50. Prasad R, Singh A. Lipids of Candida albicans and their role in multidrug resistance. Curr Genet. 2013; 59: 243-250.
51. Jensen-Pergakes KL, Kennedy MA, Lees ND, Barbuch R, Koegel C, Bard M. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants. Antimicrob Agents Chemother. 1998; 42:1160-1167.
52. Parks LW, Smith SJ, Crowley JH. Biochemical and physiological effects of sterol alterations in yeast - A review. Lipids. 1995; 30: 227-230.
53. Chung S-K, Lee K-W, Kang HI, Yamashita C, Kudo M, Yoshida Y. Design and synthesis of potential inhibitors of the ergosterol biosynthesis as antifungal agents. Bioorg Med Chem. 2000; 8: 2475-2486.
54. Kristan K, Lanišnik Rižner T. Steroid-transforming enzymes in fungi. J Steroid Biochem Mol Biol. 2012; 129: 79-91.
55. Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012; 73: 45-48.
56. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20: 133-163.